121 related articles for article (PubMed ID: 31919692)
1. Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis.
Abdel-Rahman O
Int J Clin Oncol; 2020 May; 25(5):885-891. PubMed ID: 31919692
[TBL] [Abstract][Full Text] [Related]
2. The influence of hormone replacement therapy on lung cancer incidence and mortality.
Titan AL; He H; Lui N; Liou D; Berry M; Shrager JB; Backhus LM
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1546-1556.e4. PubMed ID: 31866083
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).
Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB
Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Mortality of Lung Cancer Among Never Smokers in Relationship to Secondhand Smoking: Findings From the PLCO Trial.
Abdel-Rahman O
Clin Lung Cancer; 2020 Sep; 21(5):415-420.e2. PubMed ID: 32389507
[TBL] [Abstract][Full Text] [Related]
5. Prostate Cancer Incidence and Mortality in Relationship to Family History of Prostate Cancer; Findings From The PLCO Trial.
Abdel-Rahman O
Clin Genitourin Cancer; 2019 Aug; 17(4):e837-e844. PubMed ID: 31213414
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and lung cancer risk: a case-control analysis.
Schabath MB; Wu X; Vassilopoulou-Sellin R; Vaporciyan AA; Spitz MR
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):113-23. PubMed ID: 14734459
[TBL] [Abstract][Full Text] [Related]
7. Pre-diagnostic body mass index trajectory in relationship to lung cancer incidence and mortality; findings from the PLCO trial.
Abdel-Rahman O
Expert Rev Respir Med; 2019 Oct; 13(10):1029-1035. PubMed ID: 31414914
[No Abstract] [Full Text] [Related]
8. Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial.
Pierre-Victor D; Pinsky PF
JAMA Intern Med; 2019 Feb; 179(2):196-203. PubMed ID: 30592477
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants.
Abdel-Rahman O
Clin Breast Cancer; 2020 Aug; 20(4):300-306. PubMed ID: 32327298
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.
Tammemägi MC; Church TR; Hocking WG; Silvestri GA; Kvale PA; Riley TL; Commins J; Berg CD
PLoS Med; 2014 Dec; 11(12):e1001764. PubMed ID: 25460915
[TBL] [Abstract][Full Text] [Related]
11. Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis.
Jang YC; Huang HL; Leung CY
BMC Cancer; 2019 Dec; 19(1):1199. PubMed ID: 31818262
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.
Alford SH; Rattan R; Buekers TE; Munkarah AR
Cancer; 2015 Feb; 121(3):441-7. PubMed ID: 25533883
[TBL] [Abstract][Full Text] [Related]
13. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?
Olsson H; Bladström A; Ingvar C
Obstet Gynecol; 2003 Sep; 102(3):565-70. PubMed ID: 12962944
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy is associated with decreased survival in women with lung cancer.
Ganti AK; Sahmoun AE; Panwalkar AW; Tendulkar KK; Potti A
J Clin Oncol; 2006 Jan; 24(1):59-63. PubMed ID: 16314616
[TBL] [Abstract][Full Text] [Related]
15. Hormone Replacement Therapy and Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Symer MM; Wong NZ; Abelson JS; Milsom JW; Yeo HL
Clin Colorectal Cancer; 2018 Jun; 17(2):e281-e288. PubMed ID: 29398422
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population.
Huang B; Carloss H; Wyatt SW; Riley E
Cancer; 2009 Sep; 115(18):4167-75. PubMed ID: 19526591
[TBL] [Abstract][Full Text] [Related]
17. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer and hormone replacement therapy in the Million Women Study.
Beral V; ; Bull D; Green J; Reeves G
Lancet; 2007 May; 369(9574):1703-10. PubMed ID: 17512855
[TBL] [Abstract][Full Text] [Related]
19. The association between different hormone replacement therapy use and the incidence of lung cancer: a systematic review and meta-analysis.
Wen H; Lin X; Sun D
J Thorac Dis; 2022 Feb; 14(2):381-395. PubMed ID: 35280481
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
